Cargando…
_version_ 1784740258915549184
author Sriphoosanaphan, Supachaya
Suksawatamnuay, Sirinporn
Srisoonthorn, Nunthiya
Siripon, Nipaporn
Thaimai, Panarat
Makhasen, Wanwisar
Mungnamtrakul, Nawakodchamon
Thanapirom, Kessarin
Nonthasoot, Bunthoon
Hansasuta, Pokrath
Komolmit, Piyawat
author_facet Sriphoosanaphan, Supachaya
Suksawatamnuay, Sirinporn
Srisoonthorn, Nunthiya
Siripon, Nipaporn
Thaimai, Panarat
Makhasen, Wanwisar
Mungnamtrakul, Nawakodchamon
Thanapirom, Kessarin
Nonthasoot, Bunthoon
Hansasuta, Pokrath
Komolmit, Piyawat
author_sort Sriphoosanaphan, Supachaya
collection PubMed
description
format Online
Article
Text
id pubmed-9252411
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Association for the Study of the Liver. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92524112022-07-05 Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients Sriphoosanaphan, Supachaya Suksawatamnuay, Sirinporn Srisoonthorn, Nunthiya Siripon, Nipaporn Thaimai, Panarat Makhasen, Wanwisar Mungnamtrakul, Nawakodchamon Thanapirom, Kessarin Nonthasoot, Bunthoon Hansasuta, Pokrath Komolmit, Piyawat J Hepatol POSTER PRESENTATIONS: Saturday 25 June: Liver transplantation and hepatobiliary surgery: Clinical aspects European Association for the Study of the Liver. Published by Elsevier B.V. 2022-07 2022-07-04 /pmc/articles/PMC9252411/ http://dx.doi.org/10.1016/S0168-8278(22)01927-4 Text en Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle POSTER PRESENTATIONS: Saturday 25 June: Liver transplantation and hepatobiliary surgery: Clinical aspects
Sriphoosanaphan, Supachaya
Suksawatamnuay, Sirinporn
Srisoonthorn, Nunthiya
Siripon, Nipaporn
Thaimai, Panarat
Makhasen, Wanwisar
Mungnamtrakul, Nawakodchamon
Thanapirom, Kessarin
Nonthasoot, Bunthoon
Hansasuta, Pokrath
Komolmit, Piyawat
Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
title Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
title_full Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
title_fullStr Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
title_full_unstemmed Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
title_short Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
title_sort durability of sars-cov-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
topic POSTER PRESENTATIONS: Saturday 25 June: Liver transplantation and hepatobiliary surgery: Clinical aspects
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252411/
http://dx.doi.org/10.1016/S0168-8278(22)01927-4
work_keys_str_mv AT sriphoosanaphansupachaya durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients
AT suksawatamnuaysirinporn durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients
AT srisoonthornnunthiya durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients
AT siriponnipaporn durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients
AT thaimaipanarat durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients
AT makhasenwanwisar durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients
AT mungnamtrakulnawakodchamon durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients
AT thanapiromkessarin durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients
AT nonthasootbunthoon durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients
AT hansasutapokrath durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients
AT komolmitpiyawat durabilityofsarscov2specificimmuneresponsefollowingdifferentprimaryprimeboostvaccineplatformsandsubsequenthumoralresponsetoboosterdoseamonglivertransplantrecipients